153 related articles for article (PubMed ID: 16926095)
1. The active components and the pharmacological multi-target principle of STW 5 (Iberogast).
Wegener T; Wagner H
Phytomedicine; 2006; 13 Suppl 5():20-35. PubMed ID: 16926095
[TBL] [Abstract][Full Text] [Related]
2. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
Schemann M; Michel K; Zeller F; Hohenester B; Rühl A
Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
[TBL] [Abstract][Full Text] [Related]
3. Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components.
Schempp H; Weiser D; Kelber O; Elstner EF
Phytomedicine; 2006; 13 Suppl 5():36-44. PubMed ID: 16777393
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.
Kelber O; Wittwer A; Lapke C; Kroll U; Weiser D; Okpanyi SN; Heilmann J
Phytomedicine; 2006; 13 Suppl 5():107-13. PubMed ID: 16920344
[TBL] [Abstract][Full Text] [Related]
5. Intestinal spasmolytic effects of STW 5 (Iberogast) and its components.
Heinle H; Hagelauer D; Pascht U; Kelber O; Weiser D
Phytomedicine; 2006; 13 Suppl 5():75-9. PubMed ID: 16709451
[TBL] [Abstract][Full Text] [Related]
6. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
Ammon HP; Kelber O; Okpanyi SN
Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6.
Michael S; Kelber O; Hauschildt S; Spanel-Borowski K; Nieber K
Phytomedicine; 2009 Mar; 16(2-3):161-71. PubMed ID: 19196500
[TBL] [Abstract][Full Text] [Related]
8. Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast).
Germann I; Hagelauer D; Kelber O; Vinson B; Laufer S; Weiser D; Heinle H
Phytomedicine; 2006; 13 Suppl 5():45-50. PubMed ID: 16713223
[TBL] [Abstract][Full Text] [Related]
9. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
[TBL] [Abstract][Full Text] [Related]
10. STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.
Sibaev A; Yuece B; Kelber O; Weiser D; Schirra J; Göke B; Allescher HD; Storr M
Phytomedicine; 2006; 13 Suppl 5():80-9. PubMed ID: 16713219
[TBL] [Abstract][Full Text] [Related]
11. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D
Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
[TBL] [Abstract][Full Text] [Related]
12. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220
[TBL] [Abstract][Full Text] [Related]
13. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine.
Krueger D; Gruber L; Buhner S; Zeller F; Langer R; Seidl S; Michel K; Schemann M
Neurogastroenterol Motil; 2009 Nov; 21(11):1203-e110. PubMed ID: 19210628
[TBL] [Abstract][Full Text] [Related]
14. The herbal preparation STW 5 (Iberogast) desensitizes intestinal afferents in the rat small intestine.
Liu CY; Müller MH; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
Neurogastroenterol Motil; 2004 Dec; 16(6):759-64. PubMed ID: 15601426
[TBL] [Abstract][Full Text] [Related]
15. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men.
Pilichiewicz AN; Horowitz M; Russo A; Maddox AF; Jones KL; Schemann M; Holtmann G; Feinle-Bisset C
Am J Gastroenterol; 2007 Jun; 102(6):1276-83. PubMed ID: 17378904
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical prerequisites for a multi-target therapy.
Kroll U; Cordes C
Phytomedicine; 2006; 13 Suppl 5():12-9. PubMed ID: 16857355
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.
Khayyal MT; Seif-El-Nasr M; El-Ghazaly MA; Okpanyi SN; Kelber O; Weiser D
Phytomedicine; 2006; 13 Suppl 5():56-66. PubMed ID: 16963243
[TBL] [Abstract][Full Text] [Related]
18. [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].
Allescher HD; Wagner H
Wien Med Wochenschr; 2007; 157(13-14):301-7. PubMed ID: 17704976
[TBL] [Abstract][Full Text] [Related]
19. [Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review].
Saller R; Pfister-Hotz G; Iten F; Melzer J; Reichling J
Forsch Komplementarmed Klass Naturheilkd; 2002 Dec; 9 Suppl 1():1-20. PubMed ID: 12618546
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target.
Allescher HD; Abdel-Aziz H
Dig Dis; 2017; 35 Suppl 1():18-24. PubMed ID: 29421789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
